Efficacy of Immunotherapy With TG4040, Peg-Interferon, and Ribavirin in a Phase 2 Study of Patients With Chronic HCV Infection

This publication has 32 references indexed in Scilit:

• A Poxvirus Vaccine Is Safe, Induces T-Cell Responses, and Decreases Viral Load in Patients With Chronic Hepatitis C
  Gastroenterology, 2011
• Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
  Journal of Hepatology, 2011
• Genetics of rheumatoid arthritis: what have we learned?
  Immunogenetics, 2011
• A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals
  Journal of Hepatology, 2010
• Response definition criteria for ELISPOT assays revisited
  Cancer Immunology, Immunotherapy, 2010
• Immunogenetic characteristics of patients with autoimmune gastritis
  World Journal of Gastroenterology, 2010
• Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
  New England Journal of Medicine, 2009
• Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C
  Vaccine, 2009
• Cellular Immune Responses during High‐Dose Interferon‐α Induction Therapy for Hepatitis C Virus Infection
  The Journal of Infectious Diseases, 2009
• Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirin
  Journal of Hepatology, 2005